Connecting to SEC EDGAR… PricingSign in
← All filings

CDT

CDT Equity Inc. SEC filings
Pharmaceutical Preparations · Nasdaq, Nasdaq · Incorporated in DE
On the radar right now · 1
Nov 6, 9:15 AM ET
CDT Equity Inc.CDT
5%+ stake, may push for changes (13D) · amendment · filed by Corvus Capital Ltd.
Filing ↗
Filing history
2026-11-06
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-11-04
Prospectus 424B3
Filing ↗
2026-11-04
Current report 8-K
Shareholder rights changeBylaws change
Filing ↗
2026-11-03
Prospectus 424B3
Filing ↗
2026-10-27
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-27
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-10-27
Insider trade 4
Filing ↗
2026-10-27
Insider trade (amended) 4/A
Filing ↗
2026-10-27
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-10-27
New insider's holdings 3
Filing ↗
2026-10-27
Current report 8-K
Material agreementShare sale (dilution)Reg FD disclosure
Filing ↗
2026-10-16
PRE 14A PRE 14A
Filing ↗
2026-10-13
Prospectus 424B3
Filing ↗
2026-10-13
Current report 8-K
Material agreementNew debtShare sale (dilution)
Filing ↗
2026-10-08
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-07
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-10-07
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-07
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-02
Prospectus 424B3
Filing ↗
2026-09-25
Current report 8-K
Shareholder rights changeBylaws changeReg FD disclosure
Filing ↗
2026-09-18
Prospectus 424B3
Filing ↗
2026-09-18
Current report 8-K
Material agreementNew debtShare sale (dilution)
Filing ↗
2026-09-18
Prospectus 424B3
Filing ↗
2026-09-17
EFFECT EFFECT
Filing ↗
2026-09-09
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-09-08
Registration (share sale/IPO) S-1
Filing ↗
2026-09-04
Current report 8-K
Material agreementNew debtShare sale (dilution)
Filing ↗
2026-09-02
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-09-01
Current report 8-K
Other event
Filing ↗
2026-09-01
Current report 8-K
Exec/director changeShareholder vote
Filing ↗
2026-08-21
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-21
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-21
Current report (amended) 8-K/A
Filing ↗
2026-08-21
Current report (amended) 8-K/A
Acquisition/sale completed
Filing ↗
2026-08-12
Quarterly report 10-Q
Filing ↗
2026-08-12
Proxy material DEFA14A
Filing ↗
2026-08-11
Annual report to shareholders ARS
Filing ↗
2026-08-11
Proxy statement (shareholder vote) DEF 14A
Filing ↗